Newman Michael James
SEC insider (Form 3/4/5 filer). CIK 0001876315. CSO and Director at Indaptus Therapeutics, Inc. (INDP). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 22, 2025. Located in NEW YORK, NY.
Companies Newman Michael James has filed insider reports for
- Indaptus Therapeutics, Inc. (INDP): Director, Officer, 10% Owner, CSO and Director
Newman Michael James
CIK: 0001876315
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INDP
Indaptus Therapeutics, Inc.
DirectorOfficer10% Owner